Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
16-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
16-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #80055
advertisement
Miraftabi A
6
Showing records 1 to 6 |
Display all abstracts from
Miraftabi A
60574
Is the GSTM1 null polymorphism a risk factor for primary angle-closure glaucoma among Iranian population?
Safa FK
Acta Medica Iranica
2015; 53: 112-116
60258
Phenotype and Genotype Correlation in Iranian Primary Congenital Glaucoma Patients
Yazdani S
Journal of Glaucoma
2016; 25: 33-38
60574
Is the GSTM1 null polymorphism a risk factor for primary angle-closure glaucoma among Iranian population?
Shahsavari G
Acta Medica Iranica
2015; 53: 112-116
60258
Phenotype and Genotype Correlation in Iranian Primary Congenital Glaucoma Patients
Miraftabi A; Pakravan M
Journal of Glaucoma
2016; 25: 33-38
60574
Is the GSTM1 null polymorphism a risk factor for primary angle-closure glaucoma among Iranian population?
Miraftabi A
Acta Medica Iranica
2015; 53: 112-116
60258
Phenotype and Genotype Correlation in Iranian Primary Congenital Glaucoma Patients
Ghahari E; Tousi BK; Sedigh M; Yaseri M; Elahi E
Journal of Glaucoma
2016; 25: 33-38
Issue
16-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept